"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to EDIT. [ FAQ on what and how to ask] For non-EDIT questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Gilmore O'Neill M.D.
Headquarter: 11 Hurley Street, Cambridge, MA, United States, 02141
Industry: Biotechnology, Employees: 246
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
My Watchlist
